Neuralgia-inducing cavitational osteonecrosis
Neuralgia-Inducing Cavitational Osteonecrosis (NICO) is a controversial condition described in the field of dentistry and oral surgery. It is characterized by the presence of cavitations or holes in the jawbone, which are not detectable by standard X-rays. These lesions are believed by some practitioners to cause neuralgia (nerve pain) and other systemic health problems. The concept of NICO has been a subject of debate within the medical and dental communities due to the lack of consensus on diagnostic criteria and treatment protocols.
Etiology[edit]
The exact cause of NICO is not well understood. It is hypothesized that these jawbone cavitations may result from an inadequate supply of blood (ischemia), leading to the death of bone tissue (osteonecrosis). Factors that have been suggested to contribute to the development of NICO include trauma, infection, the extraction of wisdom teeth, and the use of certain medications known to affect bone health, such as bisphosphonates.
Symptoms[edit]
Individuals with NICO may experience a range of symptoms, including but not limited to:
- Severe facial or jaw pain
- A feeling of heaviness in the jaw
- Chronic fatigue
- Various neurological symptoms
Diagnosis[edit]
Diagnosing NICO is challenging, as the lesions are often not visible on conventional dental X-rays. Some practitioners use Cone Beam Computed Tomography (CBCT) scans, which provide a three-dimensional view of the bone, to detect these cavitations. However, there is no universally accepted diagnostic protocol for NICO, and the condition is not widely recognized in the broader medical and dental communities.
Treatment[edit]
Treatment approaches for NICO vary and may include surgical removal of the affected bone tissue, followed by therapies aimed at promoting bone healing and regeneration. Some practitioners also recommend dietary changes, supplementation, and other holistic approaches as part of the treatment plan. However, due to the controversial nature of NICO, there is limited scientific evidence supporting the effectiveness of these treatments.
Controversy[edit]
The concept of NICO remains controversial, with skepticism from many in the medical and dental fields. Critics argue that there is insufficient scientific evidence to support the existence of NICO as a distinct clinical condition and question the validity of the proposed diagnostic methods and treatments. Proponents of NICO, however, believe that it is an underrecognized cause of chronic pain and other systemic health issues.
Conclusion[edit]
Neuralgia-Inducing Cavitational Osteonecrosis represents a contentious topic within health care, with ongoing debate regarding its existence, diagnosis, and treatment. Further research is needed to clarify the nature of NICO and to develop evidence-based guidelines for its management.
Ad. Transform your health with W8MD Weight Loss, Sleep & MedSpa

Tired of being overweight?
Special offer:
Budget GLP-1 weight loss medications
- Semaglutide starting from $29.99/week and up with insurance for visit of $59.99 and up per week self pay.
- Tirzepatide starting from $45.00/week and up (dose dependent) or $69.99/week and up self pay
✔ Same-week appointments, evenings & weekends
Learn more:
- GLP-1 weight loss clinic NYC
- W8MD's NYC medical weight loss
- W8MD Philadelphia GLP-1 shots
- Philadelphia GLP-1 injections
- Affordable GLP-1 shots NYC
|
WikiMD Medical Encyclopedia |
Medical Disclaimer: WikiMD is for informational purposes only and is not a substitute for professional medical advice. Content may be inaccurate or outdated and should not be used for diagnosis or treatment. Always consult your healthcare provider for medical decisions. Verify information with trusted sources such as CDC.gov and NIH.gov. By using this site, you agree that WikiMD is not liable for any outcomes related to its content. See full disclaimer.
Credits:Most images are courtesy of Wikimedia commons, and templates, categories Wikipedia, licensed under CC BY SA or similar.
Translate this page: - East Asian
中文,
日本,
한국어,
South Asian
हिन्दी,
தமிழ்,
తెలుగు,
Urdu,
ಕನ್ನಡ,
Southeast Asian
Indonesian,
Vietnamese,
Thai,
မြန်မာဘာသာ,
বাংলা
European
español,
Deutsch,
français,
Greek,
português do Brasil,
polski,
română,
русский,
Nederlands,
norsk,
svenska,
suomi,
Italian
Middle Eastern & African
عربى,
Turkish,
Persian,
Hebrew,
Afrikaans,
isiZulu,
Kiswahili,
Other
Bulgarian,
Hungarian,
Czech,
Swedish,
മലയാളം,
मराठी,
ਪੰਜਾਬੀ,
ગુજરાતી,
Portuguese,
Ukrainian
